Loading clinical trials...
Loading clinical trials...
A Nonrandomized Phase II Study: Feasibility and Outcome of Neo Adjuvant Chemotherapy With Oxaliplatin, Fluorodeoxyuridine (FUdR), Taxotere and Leucovorin in the Treatment of Previously Untreated Advanced Esophago-Gastric Carcinoma
Conditions
Interventions
Docetaxel
Floxuridine
+5 more
Locations
1
United States
University of Miami Sylvester Comprehensive Cancer Center - Miami
Miami, Florida, United States
Start Date
October 1, 2004
Primary Completion Date
April 1, 2010
Completion Date
April 1, 2010
Last Updated
February 7, 2017
NCT04674267
NCT07217704
NCT07464470
NCT07132918
NCT07367516
NCT06346080
Lead Sponsor
University of Miami
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions